Add-on Acquisition • Life Science

Agennix AG Acquires GPC Biotech

On November 5, 2009, Agennix AG acquired life science company GPC Biotech

Acquisition Context

This is Agennix AG’s 1st transaction in the Life Science sector.
This is Agennix AG’s 1st transaction in the United States.
This is Agennix AG’s 1st transaction in New Jersey.

Explore All 3110 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	November 5, 2009
Target	GPC Biotech
Sector	Life Science
Buyer(s)	Agennix AG
Deal Type	Add-on Acquisition

Target Company

GPC Biotech

Princeton, New Jersey, United States

GPC Biotech is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Agennix AG

Heidelberg, Germany

Category	Company
Sector	Life Science
Employees	52

DESCRIPTION

Agennix AG is a biopharmaceutical company. The Company’s clinical development programs include oral talactoferrin alfa; a topical gel form of talactoferrin and RGB-286638, a multi-targeted kinase inhibitor.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: New Jersey	1 of 1
Country: United States	1 of 1
Year: 2009	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - New Jersey M&A - United States M&A - 2009 M&A